Key Advances in MIP-based Sensors Applied for Cancer and Cardiovascular Biomarkers Detection

Cancer and cardiovascular diseases have become one of the leading causes of death worldwide. Therefore, early detection of these diseases and rapid intervention by medical staff remain a great challenge for clinicians and healthcare providers worldwide. Cancer and cardiovascular disease biomarkers are promising tools for early diagnosis before it becomes incurable at an advanced stage. They also contribute to monitoring the progress of therapy and surgical treatment. Indeed, sensors have shown great importance for detecting cancer and cardiovascular biomarkers. Sensors usually require a recognition element for the selective detection of targets. Molecularly imprinted polymer (MIP), as an artificial antibody, has been proposed as an alternative recognition element in sensing fields to overcome the main drawbacks of natural antibodies. With the high need for sensors providing results quicklyand making the early diagnosis of these diseases easier, MIP-based sensors are attracting considerable interest recently, which will undoubtedly be increased in the future due to the sustainability trend. The key aim of this review is to emphasize the recent applications of sensors based on MIP for the detection of cancer and cardiovascular biomarkers and to highlight the key advances related to MIP-based sensors. Furthermore, several key future trends about the applications of MIP-based sensors for detecting cardiovascular and cancer biomarkers are presented.

Automated summary

Cancer and cardiovascular diseases are leading causes of death globally. Early detection and intervention remain a challenge for healthcare providers. MIP-based sensors show promise in the detection of biomarkers for these diseases, providing selective and rapid results. This review highlights recent applications and future trends of MIP-based sensors in detecting cancer and cardiovascular biomarkers.